TLSA NASDAQ
Tiziana Life Sciences Ltd
1W: +10.9%
1M: +20.2%
3M: -4.3%
YTD: -30.0%
1Y: -42.6%
3Y: +67.2%
5Y: -25.8%
$1.12
-0.02 (-1.75%)
Weekly Expected Move ±20.0%
$1
$1
$1
$1
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$11M
-7.4% ▼
5Y CAGR: +44.2%
Total Liabilities
$7M
+10.5% ▲
5Y CAGR: +4.2%
Shareholders Equity
$4M
-28.9% ▼
Cash & Investments
$4M
+214.8% ▲
5Y CAGR: +89.3%
Total Debt
$106K
-57.1% ▼
5Y CAGR: -29.8%
Net Debt
-$4M
-286.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $66M | $42M | $18M | $1M | $4M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $66M | $42M | $18M | $1M | $4M |
| Net Receivables | $4M | $5M | $6M | $6M | $4M |
| Inventory | -$2K | $0 | $0 | $0 | $0 |
| Other Current Assets | $193K | $0 | $0 | $0 | $0 |
| Total Current Assets | $70M | $49M | $24M | $7M | $8M |
| Property, Plant & Equip. | $360K | $17K | $389K | $293K | $187K |
| Goodwill & Intangibles | $97K | $130K | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $2M | $5M | $4M |
| Other Non-Current Assets | $23K | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $480K | $147K | $2M | $5M | $4M |
| Total Assets | $71M | $49M | $26M | $12M | $11M |
| — Liabilities — | |||||
| Accounts Payable | $3M | $4M | $5M | $4M | $6M |
| Short-Term Debt | $2M | $1M | $122K | $138K | $106K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $591K | -$1M | -$113K | -$124K | -$94K |
| Total Current Liabilities | $8M | $8M | $7M | $7M | $7M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $207 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $290K | $0 | $243K | $109K | $0 |
| Total Liabilities | $8M | $8M | $7M | $7M | $7M |
| — Equity — | |||||
| Common Stock | $97K | $102K | $102K | $103K | $111K |
| Retained Earnings | -$85M | -$108M | -$116M | -$134M | -$145M |
| Accumulated OCI | -$52K | $119M | $116M | $117M | $117M |
| Total Stockholders Equity | $46M | $41M | $20M | $6M | $4M |
| Total Liabilities & Equity | $71M | $49M | $26M | $12M | $11M |
| — Key Metrics — | |||||
| Total Debt | $555K | $1M | $365K | $247K | $106K |
| Net Debt | -$65M | -$42M | -$18M | -$936K | -$4M |
| Total Investments | $0 | $0 | $2M | $5M | $4M |